Rong-hwa Lin PhD

Dr. Lin is founder and CEO of AbGenomics. To efficiently collaborate with top talents and key opinion leaders in both inflammation and cancer fields, the company established twin-headquarters in both San Francisco Bay Area and Taipei. He is the key inventor of 13 granted and 13 pending worldwide patents. Under his leadership and well established collaborative culture, the company discovered 6 promising new therapeutic candidates and has filed 5 INDs and completed 4 mid-stage clinical trials successfully. The lead compound his team discovered has demonstrated significant clinical proof of efficacy in 3 different diseases. Prior to joining AbGenomics, Dr. Lin was founding Professor and Director of Graduate Institute of Immunology, College of Medicine, National Taiwan University. He received his “Diplom” Degree in Biotechnology, Summa Cum Laude, and Doctor Degree in Immunology, Magna Cum Laude, from the University of Tübingen in Germany.